Sign in to follow
Search Results

0 results for 'Valeant Pharmaceuticals International Inc'

You can use to get even better search results
November 12, 2014 |

Allergan Shareholders' Push to Replace Board Foiled as Premature

Allergan shareholders' effort to replace the Botox manufacturer's entire board with directors who support a proposed $5.3 billion acquisition by Valeant Pharmaceuticals International was dealt a setback last week when the Delaware Court of Chancery ruled their claim was not ripe for adjudication.
4 minute read
November 07, 2014 |

Dealmaker of the Week: Sullivan & Cromwell's Krishna Veeraraghavan

The firm's partner and cohead of technology finance and mergers and acquisitions led the legal team advising on diagnostic testing company Laboratory Corporation of America's buy of clinical trial research company Covance Inc. for $6.1 billion in cash and stock.
4 minute read
November 05, 2014 |

Latham Vows Extra Rounds in Allergan Takeover Fight

Allergan and its lawyers at Latham & Watkins filed a notice of appeal on Wednesday after a judge largely sided with hostile bidder Valeant Pharmaceuticals and the activist hedge fund Pershing Square.
3 minute read
September 18, 2014 |

Allergan and the Odd Couple

In his Corporate Securities column, John C. Coffee Jr., the Adolf A. Berle Professor of Law at Columbia University Law School, writes: Pershing Square Capital Management L.P. and Valeant Pharmaceuticals International have entered into a short-term marriage of convenience to facilitate Valeant's hostile acquisition of Allergan in a $53 billion deal. As with many relationships, onlookers have questions.
15 minute read
August 12, 2014 |

Top Tax Lawyers Mum on Inversion Debate

More than a decade ago, when corporate inversions came under scrutiny, a group of leading New York tax lawyers—headed by a Paul Weiss partner and including partners from Skadden, Sullivan & Cromwell, and Cravath—took a principled stand and called for urgent action to stop these deals. Twelve years later, a new wave of inversions has sparked controversy and calls for reform. This time the corporate tax bar's lawyers are silent.
7 minute read
August 01, 2014 |

Latham, Wachtell File Takeover Defense Suit for Allergan

Allergan claims that hostile bidder Valeant colluded with activist investor Bill Ackman, enabling Ackman's hedge fund Pershing Square to trade on inside information.
2 minute read
July 24, 2014 |

Heightened Activist Attacks on Boards of Directors

In their Corporate Governance column, David A. Katz, a partner at Wachtell, Lipton, Rosen & Katz, and Laura A. McIntosh, a consulting attorney for the firm, write: The tactics being used by today's activist investors in their approaches to corporate targets are unprecedented. Boards should be forewarned and forearmed as they pursue their plans for long-term value creation in the current, precarious environment that clearly favors the activist investor.
14 minute read
July 22, 2014 |

Valeant Complains to Regulators About Allergan

In its effort to ward off a $53 billion hostile takeover, Allergan Inc. allegedly made false and misleading statements about Valeant Pharmaceuticals International Inc.'s business over the past few months, Valeant reported to the Securities and Exchange Commission and regulators in Canada.
2 minute read
July 07, 2014 |

Dava Sold to Endo for $545M

Pharmacueutical week in N.J.: Valeant spends $41 million, while Dava is sold for $545 million.
1 minute read
June 30, 2014 |

Big Deals

AT&T/DirecTV; Alibaba IPO; Valeant / Allergan
8 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Creating a Culture of Compliance

      Brought to you by Ironclad

      Download Now

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now